0.369
price down icon2.61%   -0.0099
 
loading
전일 마감가:
$0.3789
열려 있는:
$0.379
하루 거래량:
138.15K
Relative Volume:
0.69
시가총액:
$5.67M
수익:
-
순이익/손실:
$-19.09M
주가수익비율:
-0.17
EPS:
-2.17
순현금흐름:
$-16.92M
1주 성능:
-4.40%
1개월 성능:
-3.91%
6개월 성능:
-35.83%
1년 성능:
-63.10%
1일 변동 폭
Value
$0.361
$0.385
1주일 범위
Value
$0.36
$0.3996
52주 변동 폭
Value
$0.3154
$1.74

Organovo Holdings Inc Stock (ONVO) Company Profile

Name
명칭
Organovo Holdings Inc
Name
전화
858-224-1000
Name
주소
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
Name
직원
20
Name
트위터
@Organovo
Name
다음 수익 날짜
2025-02-21
Name
최신 SEC 제출 서류
Name
ONVO's Discussions on Twitter

ONVO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ONVO
Organovo Holdings Inc
0.369 5.67M 0 -19.09M -16.92M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2018-12-13 개시 H.C. Wainwright Buy
2017-11-10 다운그레이드 Raymond James Outperform → Mkt Perform
2017-01-25 개시 Raymond James Outperform
2015-08-11 다운그레이드 Cantor Fitzgerald Buy → Hold
2015-06-29 개시 Jefferies Buy
2015-06-29 개시 Piper Jaffray Overweight
모두보기

Organovo Holdings Inc 주식(ONVO)의 최신 뉴스

pulisher
Feb 21, 2025

Organovo Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 21, 2025
pulisher
Feb 19, 2025

Organovo: Fiscal Q3 Earnings Snapshot - Thehour.com

Feb 19, 2025
pulisher
Feb 19, 2025

Organovo: Fiscal Q3 Earnings Snapshot -February 19, 2025 at 09:18 am EST - Marketscreener.com

Feb 19, 2025
pulisher
Feb 19, 2025

ORGANOVO HOLDINGS, INC. SEC 10-Q Report - TradingView

Feb 19, 2025
pulisher
Feb 15, 2025

Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Organovo Holdings Delays Quarterly Report Filing - TipRanks

Feb 14, 2025
pulisher
Feb 12, 2025

3D Bioprinting and Bioink Market is set to Fly Massive Growth in Years to Come: Organovo, Cellink, RegenHU - openPR

Feb 12, 2025
pulisher
Feb 10, 2025

Organovo (NASDAQ:ONVO) Research Coverage Started at StockNews.com - Defense World

Feb 10, 2025
pulisher
Feb 06, 2025

3D Bioprinting Market Research Report USD 6.4 Billion - openPR

Feb 06, 2025
pulisher
Feb 06, 2025

Organovo (ONVO) Projected to Post Earnings on Thursday - Defense World

Feb 06, 2025
pulisher
Jan 30, 2025

Organ On Chip Market Growing Rapidly: Emulate Inc., Mimetas B.V., Insphero, Organovo Holdings - openPR

Jan 30, 2025
pulisher
Jan 28, 2025

Next Generation Bioprinting Market Top Companies StudyEOS - openPR

Jan 28, 2025
pulisher
Jan 27, 2025

3D Bioprinting Market: Future Scope, Growth Potential, - openPR

Jan 27, 2025
pulisher
Jan 22, 2025

Organovo faces potential Nasdaq delisting - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

3D Bioprinting Technology Market to Witness Stunning Growth | - openPR

Jan 22, 2025
pulisher
Jan 18, 2025

Organovo faces potential Nasdaq delisting By Investing.com - Investing.com UK

Jan 18, 2025
pulisher
Jan 17, 2025

3D Bioprinting in Medical Market Worth $4.9 billion by 2032 | - openPR

Jan 17, 2025
pulisher
Jan 14, 2025

Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World

Jan 14, 2025
pulisher
Jan 06, 2025

Organovo names new CFO amid clinical advancements By Investing.com - Investing.com Nigeria

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo Appoints Norman Staskey as Chief Financial Officer - citybiz

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo Announces Appointment of Norman Staskey as Chief Financial Officer - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo names new CFO amid clinical advancements - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo Appoints M&A Veteran CFO as FXR314 Drug Shows Promising Phase 2 Results - StockTitan

Jan 06, 2025
pulisher
Jan 06, 2025

Organovo (NASDAQ:ONVO) Coverage Initiated at StockNews.com - Defense World

Jan 06, 2025
pulisher
Dec 31, 2024

Organovo appoints new president and CFO amid strategic plans By Investing.com - Investing.com Nigeria

Dec 31, 2024
pulisher
Dec 31, 2024

Organovo appoints new president and CFO amid strategic plans - Investing.com India

Dec 31, 2024
pulisher
Dec 31, 2024

Organovo Holdings Appoints Norman Staskey as New CFO - TipRanks

Dec 31, 2024
pulisher
Dec 22, 2024

Analyzing Sorrento Therapeutics (OTCMKTS:SRNEQ) and Organovo (NASDAQ:ONVO) - Defense World

Dec 22, 2024
pulisher
Dec 18, 2024

Top 10 4D Printing Companies | Provides Best TechMarket.us Scoop - Market.us Scoop - Market News

Dec 18, 2024
pulisher
Dec 18, 2024

Healthcare 4D Printing Market Top Companies Study3D Systems - openPR

Dec 18, 2024
pulisher
Dec 17, 2024

3D Print Organ Market 2024 to Witness Huge Growth by 2032 Prominent Players are Organovo Holdings, EnvisionTEC - openPR

Dec 17, 2024
pulisher
Dec 16, 2024

3D Bioprinting for Tissue and Organ Regeneration Market Top - openPR

Dec 16, 2024
pulisher
Dec 12, 2024

3D Bioprinting Equipment Sales Market Overview, Future Trends - openPR

Dec 12, 2024
pulisher
Dec 09, 2024

3D-Printed Organs Market is experiencing new opportunities & competitive edge highlighted by Top Market Key Players (Organovo Holdings Inc., Modern Meadow, Poietis, REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc.) | Forecast to 2030 - Industry Today

Dec 09, 2024
pulisher
Dec 06, 2024

Empowering Growth: Bioprinting Services Market 2024 - openPR

Dec 06, 2024
pulisher
Dec 04, 2024

3D Bioprinting Market is Forecast to Achieve USD 2.0 Billion - openPR

Dec 04, 2024
pulisher
Dec 01, 2024

ONVO (Organovo Holdings) Enterprise Value : $5.31 Mil (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Nov 23, 2024

Organovo expands equity incentive plan following stockholder approval By Investing.com - Investing.com Nigeria

Nov 23, 2024
pulisher
Nov 22, 2024

Organovo expands equity incentive plan following stockholder approval - Investing.com

Nov 22, 2024
pulisher
Nov 22, 2024

Organovo Holdings Gains Approval for Key Strategic Moves - TipRanks

Nov 22, 2024
pulisher
Nov 21, 2024

Industrial 3D Printing Market Size Analysis and Top Companies - Precedence Research

Nov 21, 2024
pulisher
Nov 21, 2024

ONVOOrganovo Holdings Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Organovo reports positive Phase 2 results for liver drug FXR314 By Investing.com - Investing.com Australia

Nov 21, 2024
pulisher
Nov 20, 2024

Organovo reports positive Phase 2 results for liver drug FXR314 - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - The Manila Times

Nov 20, 2024

Organovo Holdings Inc (ONVO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
자본화:     |  볼륨(24시간):